143 related articles for article (PubMed ID: 34718433)
1. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
Kang JS; Choi YJ; Byun Y; Han Y; Kim JH; Lee JM; Sohn HJ; Kim H; Kwon W; Jang JY
Br J Surg; 2021 Dec; 109(1):105-113. PubMed ID: 34718433
[TBL] [Abstract][Full Text] [Related]
2. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
3. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
4. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail.
Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Onoe S
Int J Surg; 2016 Nov; 35():64-68. PubMed ID: 27646614
[TBL] [Abstract][Full Text] [Related]
6. Comment on: Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
Tan Q; Ke N
Br J Surg; 2022 Jun; 109(7):e86. PubMed ID: 35233614
[No Abstract] [Full Text] [Related]
7. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland.
Hyun JJ; Rose JB; Alseidi AA; Biehl TR; Helton S; Coy DL; Kozarek RA; Rocha FG
J Surg Oncol; 2019 Aug; 120(2):262-269. PubMed ID: 31093997
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
[TBL] [Abstract][Full Text] [Related]
9. Radiographic Splenic Artery Involvement Is a Poor Prognostic Factor in Upfront Surgery for Patients with Resectable Pancreatic Body and Tail Cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Yamaue H
Ann Surg Oncol; 2021 Mar; 28(3):1521-1532. PubMed ID: 32705517
[TBL] [Abstract][Full Text] [Related]
10. Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer.
Kuriyama N; Mizuno S; Sakamoto T; Fujimura Y; Yuge T; Noguchi D; Ito T; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Nagata M; Usui M; Kishiwada M
Langenbecks Arch Surg; 2024 Jan; 409(1):39. PubMed ID: 38224370
[TBL] [Abstract][Full Text] [Related]
11. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas.
Kanda M; Fujii T; Sahin TT; Kanzaki A; Nagai S; Yamada S; Sugimoto H; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
Ann Surg; 2010 Mar; 251(3):483-7. PubMed ID: 20101172
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
[TBL] [Abstract][Full Text] [Related]
14. Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer.
Dedania N; Agrawal N; Winter JM; Koniaris LG; Rosato EL; Sauter PK; Leiby B; Pequignot E; Yeo CJ; Lavu H
J Gastrointest Surg; 2013 Aug; 17(8):1392-8. PubMed ID: 23797883
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
[TBL] [Abstract][Full Text] [Related]
16. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
Jeune F; Collard M; Augustin J; Guedj N; Marchese U; Rouquette A; Cunha AS; Sebagh M; Pessaux P; Avérous G; Wagner M; Bachet JB; Vaillant JC; Sauvanet A; Gaujoux S
Surgery; 2024 Apr; 175(4):1111-1119. PubMed ID: 38071135
[TBL] [Abstract][Full Text] [Related]
17. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.
Ariake K; Motoi F; Ohtsuka H; Fukase K; Masuda K; Mizuma M; Hayashi H; Nakagawa K; Morikawa T; Maeda S; Takadate T; Naitoh T; Egawa S; Unno M
Surg Today; 2017 Dec; 47(12):1434-1442. PubMed ID: 28434080
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.
Gantois D; Guilbaud T; Scemama U; Girard E; Picaud O; Lefevre M; Elgani M; Hamidou Z; Moutardier V; Balandraud P; Chirica M; Barbier L; Fuks D; Birnbaum DJ
Langenbecks Arch Surg; 2022 Feb; 407(1):153-165. PubMed ID: 34373941
[TBL] [Abstract][Full Text] [Related]
19. Management of isolated recurrence after surgery for pancreatic adenocarcinoma.
Kim YI; Song KB; Lee YJ; Park KM; Hwang DW; Lee JH; Shin SH; Kwon JW; Ro JS; Kim SC
Br J Surg; 2019 Jun; 106(7):898-909. PubMed ID: 31162655
[TBL] [Abstract][Full Text] [Related]
20. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
